SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Outcomes of Tamoxifen Chemoprevention for Breast Cancer in Very High-Risk Women: A Cost-Effectiveness Analysis
8 references·0 citing·33 second hop
Outcomes of Tamoxifen Chemoprevention for Breast Cancer in Very High-Risk Women: A Cost-Effectiveness Analysis (2002)Outcomes of Tamoxifen Chemoprevention for…Systematic Overview of Cost-Utility Assessments in Oncology (2000)Systematic Overview of Cost-U…Health-related Quality of Life in Economic Evaluations for Osteoporosis (1999)Health-related Quality of Lif…Gains in Life Expectancy from Medical Interventions — Standardizing Data on Outcomes (1998)Gains in Life Expectancy from…Preferences for health outcomes and cost-utility analysis. (1997)Preferences for health outcom…The Role of Cost-effectiveness Analysis in Health and Medicine (1996)The Role of Cost-effectivenes…Stage, Age, Comorbidity, and Direct Costs of Colon, Prostate, and Breast Cancer Care (1995)Stage, Age, Comorbidity, and …Medicare Payments from Diagnosis to Death for Elderly Cancer Patients by Stage at Diagnosis (1995)Medicare Payments from Diagno…Measuring Health-Related Quality of Life (1993)Measuring Health-Related Qual…EuroQol - a new facility for the measurement of health-related quality of life (1990)How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. (1992)Recommendations of the Panel on Cost-Effectiveness in Health and Medicine (1996)Health Care Economic Analyses and Value-Based Medicine (2003)HER-2 Testing and Trastuzumab Therapy for Metastatic Breast Cancer: A Cost-Effectiveness Analysis (2004)Health Utilities Using the EQ-5D in Studies of Cancer (2007)An Assessment of Clinically Useful Measures of the Consequences of Treatment (1988)Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine (1996)The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine (1996)Estimating the cost-effectiveness of 54 weeks of infliximab for rheumatoid arthritis (2002)Medical Economics and the Assessment of Value in Cardiovascular Medicine: Part I (2002)Reducing the costs of phase III cardiovascular clinical trials (2005)Measurement of health state utilities for economic appraisal (1986)Comparison of Health State Utilities Using Community and Patient Preference Weights Derived from a Survey of Patients with HIV/AIDS (2002)Patient and Community Preferences for Outcomes in Prostate Cancer (2003)SF-36 health survey: Manual and interpretation guide (2003)Measuring Preferences for Cost-Utility Analysis (2007)Cost-Effectiveness in Health and Medicine (1996)Recommendations for Reporting Cost-effectiveness Analyses (1996)Decision Making in Health and Medicine: Integrating Evidence and Values (2001)Use of Cost-Effectiveness Analysis in Health-Care Resource Allocation Decision-Making: How Are Cost-Effectiveness Thresholds Expected to Emerge? (2004)Methods for the Economic Evaluation of Health Care Programmes (2005)Core outcome domains for chronic pain clinical trials: IMMPACT recommendations (2003)Interpretation of Changes in Health-related Quality of Life (2003)The PedsQL™* 4.0 as a Pediatric Population Health Measure: Feasibility, Reliability, and Validity (2003)The Burden of Illness of Cancer: Economic Cost and Quality of Life (2001)Clinical model of lifetime cost of treating bladder cancer and associated complications (2006)Time costs associated with informal caregiving for cancer survivors (2009)Estimating the Cost of Cancer: Results on the Basis of Claims Data Analyses for Cancer Patients Diagnosed With Seven Types of Cancer During 1999 to 2000 (2004)Patient Time Costs Associated With Cancer Care (2007)Reliability, validity, and minimally important differences of the SF-6D in systemic sclerosis (2007)The Effect of Hypoglycemia on Health-Related Quality of Life: Canadian Results from a Multinational Time Trade-off Survey (2014)Value-based medicine: concepts and application (2015)
this work references cited by second hop

References

  • 1993Measuring Health-Related Quality of Life3,970 cited
  • 1996The Role of Cost-effectiveness Analysis in Health and Medicine1,168 cited
  • 1995Stage, Age, Comorbidity, and Direct Costs of Colon, Prostate, and Breast Cancer Care344 cited
  • 1998Gains in Life Expectancy from Medical Interventions — Standardizing Data on Outcomes334 cited
  • 1995Medicare Payments from Diagnosis to Death for Elderly Cancer Patients by Stage at Diagnosis332 cited
  • 2000Systematic Overview of Cost-Utility Assessments in Oncology296 cited
  • 1999Health-related Quality of Life in Economic Evaluations for Osteoporosis119 cited
  • 1997Preferences for health outcomes and cost-utility analysis.104 cited

Cited by

No citing works inside the corpus for this window.

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work